Loading...
Management of infusion reactions associated with cetuximab treatment: A case report
Cetuximab is a drug targeting the epidermal growth factor receptor, which is indicated for the treatment of unresectable advanced or recurrent head and neck or colorectal cancer. Cetuximab also enhances the cytotoxic effects of radiation in squamous cell carcinoma. The severity of infusion reactions...
Na minha lista:
| Udgivet i: | Mol Clin Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5451859/ https://ncbi.nlm.nih.gov/pubmed/28588776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1242 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|